Correlation Between Moleculin Biotech and Allovir

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Moleculin Biotech and Allovir at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Moleculin Biotech and Allovir into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Moleculin Biotech CS and Allovir, you can compare the effects of market volatilities on Moleculin Biotech and Allovir and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Moleculin Biotech with a short position of Allovir. Check out your portfolio center. Please also check ongoing floating volatility patterns of Moleculin Biotech and Allovir.

Diversification Opportunities for Moleculin Biotech and Allovir

-0.3
  Correlation Coefficient

Very good diversification

The 3 months correlation between Moleculin and Allovir is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Moleculin Biotech CS and Allovir in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allovir and Moleculin Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Moleculin Biotech CS are associated (or correlated) with Allovir. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allovir has no effect on the direction of Moleculin Biotech i.e., Moleculin Biotech and Allovir go up and down completely randomly.

Pair Corralation between Moleculin Biotech and Allovir

Given the investment horizon of 90 days Moleculin Biotech CS is expected to under-perform the Allovir. But the stock apears to be less risky and, when comparing its historical volatility, Moleculin Biotech CS is 1.32 times less risky than Allovir. The stock trades about -0.05 of its potential returns per unit of risk. The Allovir is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest  3,021  in Allovir on June 28, 2022 and sell it today you would lose (2,282)  from holding Allovir or give up 75.54% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Moleculin Biotech CS  vs.  Allovir

 Performance (%) 
       Timeline  
Moleculin Biotech 
Moleculin Performance
0 of 100
Over the last 90 days Moleculin Biotech CS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in October 2022. The current disturbance may also be a sign of long term up-swing for the company investors.

Moleculin Price Channel

Allovir 
Allovir Performance
11 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Allovir are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Allovir reported solid returns over the last few months and may actually be approaching a breakup point.

Allovir Price Channel

Moleculin Biotech and Allovir Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Moleculin Biotech and Allovir

The main advantage of trading using opposite Moleculin Biotech and Allovir positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Moleculin Biotech position performs unexpectedly, Allovir can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allovir will offset losses from the drop in Allovir's long position.
Moleculin Biotech vs. Insulet Corp
Moleculin Biotech vs. Gilead Sciences
Moleculin Biotech vs. ResMed Inc
Moleculin Biotech vs. Biogen Inc
The idea behind Moleculin Biotech CS and Allovir pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Allovir vs. K L A-Tencor
Allovir vs. Vulcan Materials
Allovir vs. Cohu Inc
Allovir vs. Nova
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Piotroski F Score module to get Piotroski F Score based on binary analysis strategy of nine different fundamentals.

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go